ASGO's Second Biennial Meeting, November 3-5 2011 by Chia, Yin Nin
Following the initial success of the Asian Society of Gyneco-
logic Oncology (ASGO) 1st Biennial Meeting Tokyo in 2009, 
the ASGO 2nd Biennial Meeting was held in the Ritz Carlton 
Hotel, Seoul from the 3 to 5 November 2011 and again, it was 
a resounding success. It saw active participation from 15 Asian 
countries as well as 5 non Asian countries (USA, UK, Canada, 
Germany, and Eritrea). The total number of registrants was 622 
with a total of 226 abstract submissions (Table 1). 
The theme for this year meeting was ‘New Insight into Gy-
necologic Cancer in Asia’ and the purpose was to serve as a 
platform for mutual exchange and sharing of the latest de-
velopments in the field of gynecologic oncology in Asia. The 
scientific program was very comprehensive (Fig. 1). It covers 
all aspects of gynecologic oncology. There were 5 plenary 
sessions, covering various pertinent management issues and 
updates in uterine, cervical, ovarian cancers and gestational 
trophoblastic diseases as well as a special plenary session on 
controversial issues in gynecologic oncology and one entire 
plenary session focusing on translational research.  There were 
3 free communication sessions and poster display with a total 
of 29 oral and 133 poster presentations. ASGO was also hon-
ored to have 4 renowned speakers from International Gyneco-
logic Cancer Society (IGCS): current President of IGCS, Shingo 
Fujii (Japan), Jonathan Ledermann (UK), Ginger Gardner (USA) 
and Jonathan Berek (USA); and another 3 from Society of 
Gynecologic Oncology (SGO): Ronald Alvarez (USA), Linus Ch-
uang (USA), and Warner Huh (USA).
The meeting started off with a special session on Interna-
tional Collaboration of Clinical Research during which there 
was active sharing of current trial programs from the Gyneco-
logic Cancer InterGroup (GCIG), Gynecologic Oncology Group 
(GOG), Japanese Gynecologic Oncology Group (JGOG) and 
Korean Gynecologic Oncology Group (KGOG). This session 
opens up avenues for future collaboration with the aim to 
improve management outcome of women with gynecologic 
cancers in Asia. Professor Soon-Beom Kang delivered the Pres-
idential Address on ‘New Asian leadership for fighting against 
gynecologic cancer’ highlighting the need for Asian leaders 
for Asian women who are a distinct group with different ge-
netic makeup and hence different disease epidemiology and 
characteristics from the Western population [1].
Part of the ASGO commitment was towards the training of 
young gynecologic oncologists in Asia to meet the rising de-
mand for gynecology oncology services in the region as the 
approximately one-half of all global cancer mortalities were 
still observed in Asia [1,2]. Thus, special to this year biennial 
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Table 1. Number of presentation and registration by country during 
ASGO 2nd biennial meeting
Country
Presentation
Registration
IL* FC PP Total
Bangladesh 1
Canada 1
China 3 4 14 21 24
Eritrea 1
Germany 1 1 1
Hong Kong 1 1 2
India 1 1 2 3
Indonesia 1 1 2 4 7
Japan 8 6 31 45 98
Korea 11 10 64 85 339
Laos 1
Malaysia 1 2 3 6
Mongolia 1
Philippine 1 1 2 12
Singapore 1 1 3 5 7
Taiwan 3 4 12 19 35
Thailand 1 1 3 5 66
UK 1 1 1
USA 5 1 6 15
Total 38 29 133 200 622
*Invited lectures include talks during special session, symposium, 
invited lecture, plenary and educational sessions.
IL, invited lecture; FC, free communication; PP, poster presentation.ASGO’s Second Biennial Meeting, November 3-5 2011
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meeting was an educational session focusing on surgery and 
surgical pathology of gynecologic malignancies from which 
many gynecologic oncology trainees benefited.
In addition to the excellent scientific program, Professor 
Joo-Hyun Nam, chairman of the local organizing committee, 
also put together a very memorable social program for the 
meeting. For both the opening ceremony and the banquet, 
participants were enthralled with both traditional and new 
age Korean performances and the warmth hospitality by the 
hosting country, Korea, was felt deep in our hearts. 
ASGO continued to grow. As of the last council meeting 
on the 5 November 2011 held in conjunction with the 2nd 
biennial meeting, we saw membership grew to 224 from 18 
countries. We also looked forward to receive a new council 
member from Malaysia.
With the success of the 2nd biennial meeting, ASGO will play 
a major role in advancing the health care standards of Asian 
women with gynecologic cancers now and in the future. Con-
gratulations to Professor Soon-Beom Kang, Joo-Hyun Nam 
and all organizing committee members for the great success 
Fig. 1. Attendees at the ASGO 2
nd Biennial Meeting, Seoul, Korea.
Fig. 2. Representative members and Award winners of various Asian countries attending the ASGO 2
nd Biennial Meeting.Yin Nin Chia
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of the ASGO 2nd biennial meeting in Seoul (Fig. 2). The 3rd 
biennial meeting will be held on 13-15 December 2013 in 
Kyoto, Japan under the direction of 2nd President of ASGO, 
Professor Toshiharu Kamura and Congress President, Professor 
Ikuo Konishi.
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